Back
International Screening Standards - IBBIS
webCredibility Rating
4/5
High(4)High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: International Biosecurity and Biosafety Initiative
Relevant to AI safety discussions around dual-use risks, as AI-assisted DNA design and synthesis could lower barriers to bioweapons development; IBBIS screening standards represent one governance layer aimed at mitigating this risk.
Metadata
Importance: 52/100standardhomepage
Summary
IBBIS (International Biosecurity and Biosafety Initiative for Science) develops and promotes international standards for screening DNA synthesis orders to prevent misuse for biological weapons development. The initiative works to establish harmonized screening protocols that DNA synthesis providers worldwide can adopt to identify potentially dangerous sequences before fulfilling orders. This represents a key governance mechanism for biosecurity in the emerging synthetic biology sector.
Key Points
- •Promotes harmonized international standards for DNA synthesis screening to reduce biological weapons proliferation risk
- •Addresses the gap in biosecurity oversight as DNA synthesis becomes cheaper and more accessible globally
- •Works with governments, industry, and scientific community to develop technically sound and implementable screening protocols
- •Screening standards aim to identify sequences of concern (e.g., select agents, enhanced pathogens) before synthesis is completed
- •Represents a coordination effort to prevent a patchwork of inconsistent national regulations creating exploitable gaps
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| IBBIS (International Biosecurity and Biosafety Initiative for Science) | Organization | 60.0 |
Cached Content Preview
HTTP 200Fetched Apr 9, 20266 KB
International Screening Standards - IBBIS
About
People
Careers
News
Our Work
Commec Sequence Screening
Customer Screening
Global Synthesis Map
International Standards
Sequence Biosecurity Standards
Vulnerability Disclosure
Contact
About
People
Careers
News
Our Work
Commec Sequence Screening
Customer Screening
Global Synthesis Map
International Standards
Sequence Biosecurity Standards
Vulnerability Disclosure
Contact
International Screening Standards
Supporting common international standards for DNA synthesis screening
IBBIS seeks to support standards for DNA synthesis screening that are international, inclusive and rigorous. There has been increasing interest in harmonizing and standardizing screening approaches around the world, especially in light of national and international guidance released in 2024 and concerns that advances in artificial intelligence will increase the risk that synthetic nucleic acids are misused. By promoting and enhancing emerging standards, we aim to prevent fragmentation of synthesis screening methodology while improving baseline practices.
The DNA Synthesis Screening Consortium (DSSC) , our flagship initiative under the International Standards programme, drives much of this work.
Launch Stakeholder engagement starting January 2025 Now Developing recommendations to strengthen existing standards Future Harmonized guidance for policymakers and standards bodies
Challenge: a fragmented landscape of voluntary guidance
Voluntary standards for sequence and customer screening have already been adopted by providers aiming to comply with their national export controls and biosecurity guidance. However, this adoption remains uneven, particularly among smaller providers. In the past few years, there has been increasing interest in harmonizing and standardizing screening practices from industry and the international organizations:
The International Gene Synthesis Consortium (IGSC) has grown to over 40 members, all of whom agree to screen orders according to a Harmonized Screening Protocol
Over 175 developers of AI for biodesign have signed the Commitments for the Responsible Development of AI for Protein Design , including the commitment to “obtain DNA synthesis services only from providers that demonstrate adherence to industry-standard biosecurity screening practices”
The 2022 WHO Global guidance framework for the responsible use of the life sciences includes a scenario in which synthetic nucleic acids are used to produce a chimeric virus, and highlights how biosecurity risks could have been avoided if the synthesis company had screened the order
ISO 20688-2:2024 , a standard for production and quality control of synthesized gene fragments, genes
... (truncated, 6 KB total)Resource ID:
8ecf5545b27f07a5 | Stable ID: sid_XjrrjGWP6t